The ACTN3 R577X variant is primarily linked to sprint and power performance, not directly to weight loss. The XX genotype (lack of alpha-actinin-3) is associated with a slight shift toward endurance fiber types, which could theoretically influence exercise response. However, evidence for a direct role in weight loss is weak: no RCTs show that knowing your ACTN3 status improves weight loss outcomes. Effect sizes are small, and environmental factors like diet, calorie balance, and training volume dominate. Consumer tests often overhype single-gene predictions. What to watch: Don't let a single SNP mislead you. Having the 'sprinter' variant doesn't mean you can't lose fat; focus on evidence-based strategies: adequate protein, calorie deficit, resistance and endurance training. If you have the XX genotype, a higher proportion of endurance training might be beneficial, but this is speculative. Safety note: Do not make drastic training or dietary changes based solely on this gene. Consult a physician for medical advice.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-45e03438382e24050a4357f5